Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$8.56 - $14.47 $448,672 - $758,445
-52,415 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$15.31 - $26.52 $802,473 - $1.39 Million
52,415 New
52,415 $848,000
Q3 2020

Nov 13, 2020

SELL
$16.2 - $25.7 $5,265 - $8,352
-325 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$5.24 - $23.4 $1,703 - $7,604
325 New
325 $8,000
Q1 2019

May 13, 2019

SELL
$3.51 - $7.3 $1.25 Million - $2.59 Million
-355,055 Closed
0 $0
Q2 2018

Aug 10, 2018

SELL
$14.2 - $22.68 $1.68 Million - $2.68 Million
-118,352 Reduced 25.0%
355,055 $6.34 Million
Q4 2017

Feb 12, 2018

BUY
$14.95 - $19.9 $7.08 Million - $9.42 Million
473,407
473,407 $7.78 Million

Others Institutions Holding MRSN

About Mersana Therapeutics, Inc.


  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $68M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Fil LTD Portfolio

Follow Fil LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.